Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score

BACKGROUND: The intermediate metabolites associated with the development of atherosclerotic cardiovascular disease (ASCVD) remain largely unknown. Thus, we conducted a large panel of metabolomics profiling to identify the new candidate metabolites that were associated with 10-year ASCVD risk. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghanbanadaki, Hojat, Dodangeh, Salimeh, Parhizkar Roudsari, Peyvand, Hosseinkhani, Shaghayegh, Khashayar, Pouria, Noorchenarboo, Mohammad, Rezaei, Negar, Dilmaghani-Marand, Arezou, Yoosefi, Moein, Arjmand, Babak, Khalagi, Kazem, Najjar, Niloufar, Kakaei, Ardeshir, Bandarian, Fatemeh, Aghaei Meybodi, Hamid, Larijani, Bagher, Razi, Farideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188945/
https://www.ncbi.nlm.nih.gov/pubmed/37206107
http://dx.doi.org/10.3389/fcvm.2023.1161761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188945/
https://www.ncbi.nlm.nih.gov/pubmed/37206107
http://dx.doi.org/10.3389/fcvm.2023.1161761

Ejemplares similares